Eisai
4523.T
#1781
Rank
C$13.06 B
Marketcap
$46.33
Share price
0.57%
Change (1 day)
-34.87%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.95

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.03. In 2022 the company made an earnings per share (EPS) of $2.23 a decrease over its 2021 EPS that were of $9.88.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9532.44%
2022$2.23-77.48%
2021$9.88-41.88%
2020$17.00-0.94%
2019$17.1652.59%
2018$11.25124.17%
2017$5.02-49.42%
2016$9.9237.08%
2015$7.24-11.75%
2014$8.20-3.23%
2013$8.48-18.56%
2012$10.41-15.51%
2011$12.32-3.75%
2010$12.80-1.36%
2009$12.97